retatrutide new england journal of medicine Retatrutide, an Amazing Future for Weight Loss Retatrutide: The New Triple-Agonist Weight

GLP-1 weight loss programs at Florida Surgery & Weight Loss Center are provided by licensed medical professionals through secure telehealth visits across Florida

See our detailed retatrutide vs semaglutide comparison for the complete analysis

Our program combines these weight loss medications with telehealth services, enabling easy access and ongoing support

The glucagon-like peptide-1 receptor--or not

Safety Monitoring: Who Needs Enhanced Lab Surveillance Patients with pre-existing kidney disease, liver cirrhosis, thyroid nodules, or personal/family history of medullary thyroid cancer require more frequent biomarker checks and may not be candidates for GLP-1 therapy

El GLP-1 para la obesidad ofrece una nueva va de avance